Australia markets closed

Orgenesis Inc. (ORGS)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.5054+0.0054 (+1.08%)
At close: 04:00PM EDT
0.5000 -0.01 (-1.07%)
After hours: 06:26PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-55,361
-55,361
-14,889
-18,053
1,110
Depreciation & amortisation
1,560
1,560
1,978
1,864
1,435
Stock-based compensation
463
463
982
1,745
19,895
Change in working capital
36,626
36,626
-19,979
-15,397
-3,276
Accounts receivable
30,060
30,060
-21,051
-12,178
-1,350
Inventory
-389
-389
-7
55
-84
Accounts payable
5,516
5,516
-1,321
-3,755
1,985
Other working capital
-16,933
-16,933
-37,340
-34,732
-79,571
Other non-cash items
1,458
1,458
1,141
503
963
Net cash provided by operating activities
-14,837
-14,837
-24,924
-26,866
-78,046
Cash flows from investing activities
Investments in property, plant and equipment
-2,096
-2,096
-12,416
-7,866
-1,525
Acquisitions, net
-1,633
-1,633
0
-242
-1,024
Purchases of investments
-33
-33
-14
-28
0
Sales/maturities of investments
-
-
-
0
18
Other investing activities
55
55
-2,811
-4,248
2,500
Net cash used for investing activities
-3,707
-3,707
-14,133
-12,384
105,610
Cash flows from financing activities
Debt repayment
-3,035
-3,035
-2,346
-1,016
-2,857
Common stock issued
5,283
5,283
2,181
1,926
8,738
Common stock repurchased
-
-
0
-1,016
-250
Other financing activities
5,000
5,000
20,593
-
-
Net cash used provided by (used for) financing activities
13,618
13,618
39,578
-106
5,881
Net change in cash
-4,926
-4,926
521
-39,356
33,445
Cash at beginning of period
6,369
6,369
5,974
45,568
12,041
Cash at end of period
1,479
1,479
6,369
5,974
45,568
Free cash flow
Operating cash flow
-14,837
-14,837
-24,924
-26,866
-78,046
Capital expenditure
-2,096
-2,096
-12,416
-7,866
-1,525
Free cash flow
-16,933
-16,933
-37,340
-34,732
-79,571